1. Home
  2. RTX vs ABT Comparison

RTX vs ABT Comparison

Compare RTX & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RTX Corporation

RTX

RTX Corporation

HOLD

Current Price

$170.71

Market Cap

234.3B

Sector

Industrials

ML Signal

HOLD

Logo Abbott Laboratories

ABT

Abbott Laboratories

HOLD

Current Price

$124.99

Market Cap

222.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RTX
ABT
Founded
1934
1888
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.3B
222.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RTX
ABT
Price
$170.71
$124.99
Analyst Decision
Buy
Strong Buy
Analyst Count
13
18
Target Price
$175.00
$146.61
AVG Volume (30 Days)
4.2M
6.5M
Earning Date
10-21-2025
01-21-2026
Dividend Yield
1.59%
1.89%
EPS Growth
38.64
141.97
EPS
4.87
7.96
Revenue
$85,988,000,000.00
$43,843,000,000.00
Revenue This Year
$8.82
$7.56
Revenue Next Year
$6.17
$7.96
P/E Ratio
$35.14
$15.71
Revenue Growth
8.79
6.37
52 Week Low
$112.27
$110.86
52 Week High
$181.31
$141.23

Technical Indicators

Market Signals
Indicator
RTX
ABT
Relative Strength Index (RSI) 47.30 41.37
Support Level $166.74 $124.06
Resistance Level $172.09 $129.85
Average True Range (ATR) 3.23 2.81
MACD -0.71 -0.21
Stochastic Oscillator 35.57 27.79

Price Performance

Historical Comparison
RTX
ABT

About RTX RTX Corporation

RTX is an aerospace and defense manufacturer formed from the merger of United Technologies and Raytheon, with roughly equal exposure across three segments, mostly as a supplier to commercial aerospace and to the defense market: Collins Aerospace, a diversified aerospace supplier; Pratt & Whitney, a commercial and military aircraft engine manufacturer; and Raytheon, a defense prime contractor providing a mix of missiles, missile defense systems, sensors, hardware, and communications technology to the military.

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Share on Social Networks: